Target intelligence / Profile preview

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1)

Target
SHIP-1
Molecular classification
Enzyme, Phosphatase
01

Overview

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1), encoded by the INPP5D gene, is a key negative regulator of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, primarily expressed in hematopoietic cells and microglia. By hydrolyzing the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PIP3) to produce phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), SHIP-1 acts as an enzymatic brake on immune cell activation, proliferation, and survival. In the central nervous system, SHIP-1 inhibits TREM2/DAP12 signaling in microglia, thereby restricting neuroprotective microglial responses such as phagocytosis and amyloid-beta clearance. Consequently, SHIP-1 has emerged as a major therapeutic target in late-onset Alzheimer's disease, where small-molecule inhibitors are being developed to boost microglial clearance of plaques. Conversely, SHIP-1 activators, such as the clinical-stage candidate rosiptor (AQX-1125), have been investigated for their anti-inflammatory properties in treating inflammatory and autoimmune diseases by dampening overactive PI3K signaling.

Other names
Inositol polyphosphate-5-phosphatase DSH2 domain-containing inositol 5'-phosphatase 1SH2 domain-containing inositol phosphatase 1SHIP1SIP-145p150ShipINPP5D
02

Mechanism of action

Allosteric activation of SHIP-1 to enhance its phosphatase activity and suppress PI3K/Akt signaling, or competitive inhibition of SHIP-1 to block its phosphatase activity, thereby enhancing TREM2 signaling and microglial phagocytosis.

03

Biological functions

Signal transductionImmune responsePhagocytosisCell proliferationApoptosisCell survivalCell migration
04

Disease associations

Alzheimer's diseaseCancerInflammationAutoimmune diseaseLeukemiaInflammatory bowel disease
05

Safety considerations

MyelosuppressionBone loss / osteoporosisAutoimmune reactionsPulmonary inflammationImpaired adaptive immunityAnergy
06

Interacting drugs

Rosiptor (AQX-1125)

3 more in the full profile.

07

Biomarkers

INPP5D expression levelsAkt phosphorylation (p-Akt)PIP3 levelsNLRP3 inflammasome activationMicroglial phagocytic activity

Beyond the preview

Go deeper on Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call